Marc Suárez-Calvet 🧠🧪 🩺🌈
@M_SuarezCalvet
Neurologist and scientist at BarcelonaBeta Brain Research Center @fpmaragall and Hospital del Mar. @ERC_Research Starting Grant - HeBe Project 🧠🩸
I am truly honoured and humbled to be awarded with an ERC Starting Grant to start my group in #Barcelona and investigate 🩸 biomarkers of #Alzheimers #ageing @fpmaragall @the_prbb @imimat @hospitaldelmar #ERCStG @ERC_Research #ENDALZ @ComissioEuropea @PrensaCE @biocat_cat 1/n
NEWS: ERC Starting Grants worth €677 million awarded to 436 excellent early-career researchers. Discover the details. erc.europa.eu/news/StG-recip… #ERCStG 🇪🇺#EUfunded
New paper out! A new study led by researchers at the #BBRC highlights the potential of a blood-based biomarker panel to detect early signs of Alzheimer’s disease in middle-aged individuals with no evident cognitive symptoms. barcelonabeta.org/en/news/news/n…
Buscamos neurólogos/as para unirse a @BarcelonaBeta @fpmaragall 🧠👩🏻⚕️ ➡️estudios observacionales, ensayos clínicos ➡️investigación (con opciones de PhD y postdoc), ➡️actividad clínica en @hospitaldelmar Aplica en el enlace👇 barcelonabeta.org/es/centro-inve…
🚨 The European Commission has officially approved #lecanemab as a treatment for early-stage Alzheimer's disease. This marks a major milestone in tackling the disease at its root. ⤵️📰 barcelonabeta.org/en/news/news/e…
Lecanemab has been approved in Europe—the first disease-modifying treatment for #Alzheimer . Now, from public health centers, we must ensure equitable access, minimize risks, and offer the best care. 🧠🏥💚 @BarcelonaBeta @fpmaragall @hospitaldelmar ec.europa.eu/newsroom/sante…
🔴 Ja es pot diagnosticar l'Alzheimer amb una analítica "El neuròleg fa diverses proves i una que ens pot ajudar pot ser aquest biomarcador en sang, que sempre ha d'interpretar l'especialista", Marc Suárez-Calvet, investigador @hospitaldelmar i @fpmaragall #TotEsMou3Cat
Using data from 1,767 patients across 5 medical centers, researchers validated Lumipulse p-tau217—an automated, scalable system with an accuracy in hospital settings over 90%, comparable to that of a lumbar puncture. barcelonabeta.org/en/news/news/b…
New study compares plasma #biomarkers for detecting #Alzheimer’s disease in memory clinics The plasma p-tau biomarkers demonstrated superior accuracy in detecting Alzheimer's compared to other biomarkers #Neurologia @BarcelonaBeta @HMar_research hospitaldelmar.cat/en/noticies/vi…
Please share! Great opportunity in an amazing environment.
Thrilled to be back home at @BarcelonaBeta as the Lead of the Neuroimaging Group! 🎉 Even better, we have a PhD position open to work with PET & MRI imaging in early stages of #Alzheimer’s. If you know someone passionate about neuroimaging, please share👇 barcelonabeta.org/es/centro-inve…
🗨️@M_SuarezCalvet, neurólogo de @fpmaragall: "Es importante destacar que esta recomendación no implica una disponibilidad inmediata del fármaco en toda Europa, ya que cada país deberá decidir si se incluye en su sistema de salud pública" sciencemediacentre.es/la-ema-revisa-…
📢La Agencia Europea de Medicamentos @EMA_News he emitido una recomendación positiva sobre la autorización de comercialización de lecanemab en Europa, un fármaco que ralentiza el progreso de la enfermedad de #Alzheimer en sus primeras fases. fpmaragall.org/noticias/la-em…